TELES Informationstechnologien AG (TLIK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, TELES Informationstechnologien AG (TLIK) has a cash flow conversion efficiency ratio of x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€12.77K ≈ $14.93K USD) by net assets (€0.00 ≈ $0.00 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TELES Informationstechnologien AG balance sheet quality to measure how much of total assets are equity-financed.
TELES Informationstechnologien AG - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how TELES Informationstechnologien AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check TLIK cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
TELES Informationstechnologien AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TELES Informationstechnologien AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sobr Safe Inc
NASDAQ:SOBR
|
-0.982x |
|
Foncière Euris SA
PA:EURS
|
-0.116x |
|
Ion Energy Ltd
V:ION
|
-0.208x |
|
Innovation Beverage Group Limited
NASDAQ:IBG
|
-0.413x |
|
Airesis SA
SW:AIRE
|
0.045x |
|
AGM Group Holdings Inc Class A
NASDAQ:AGMH
|
-0.078x |
|
SRx Health Solutions Inc.
NYSE MKT:SRXH
|
18.676x |
|
Diaceutics PLC
LSE:DXRX
|
0.021x |
Annual Cash Flow Conversion Efficiency for TELES Informationstechnologien AG (2003–2024)
The table below shows the annual cash flow conversion efficiency of TELES Informationstechnologien AG from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of TELES Informationstechnologien AG.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €0.00 ≈ $0.00 |
€-1.41 Million ≈ $-1.64 Million |
x | -- |
| 2023-12-31 | €-5.10 Million ≈ $-5.97 Million |
€193.00K ≈ $225.64K |
-0.038x | -59.33% |
| 2022-12-31 | €379.23K ≈ $443.36K |
€-9.00K ≈ $-10.52K |
-0.024x | +86.39% |
| 2021-12-31 | €1.61 Million ≈ $1.88 Million |
€-280.65K ≈ $-328.11K |
-0.174x | +99.76% |
| 2020-12-31 | €13.30K ≈ $15.55K |
€-986.42K ≈ $-1.15 Million |
-74.156x | -- |
| 2019-12-31 | €0.00 ≈ $0.00 |
€-660.30K ≈ $-771.96K |
x | -- |
| 2018-12-31 | €-9.46 Million ≈ $-11.06 Million |
€-1.04 Million ≈ $-1.22 Million |
0.110x | +15.21% |
| 2017-12-31 | €-9.62 Million ≈ $-11.25 Million |
€-920.00K ≈ $-1.08 Million |
0.096x | -22.97% |
| 2016-12-31 | €-10.15 Million ≈ $-11.86 Million |
€-1.26 Million ≈ $-1.47 Million |
0.124x | -7.88% |
| 2015-12-31 | €-13.19 Million ≈ $-15.42 Million |
€-1.78 Million ≈ $-2.08 Million |
0.135x | +859.46% |
| 2014-12-31 | €-11.75 Million ≈ $-13.73 Million |
€-165.00K ≈ $-192.90K |
0.014x | -91.34% |
| 2013-12-31 | €-10.33 Million ≈ $-12.07 Million |
€-1.68 Million ≈ $-1.96 Million |
0.162x | +187.11% |
| 2012-12-31 | €-10.65 Million ≈ $-12.45 Million |
€-602.00K ≈ $-703.80K |
0.057x | -89.49% |
| 2011-12-31 | €-7.73 Million ≈ $-9.03 Million |
€-4.15 Million ≈ $-4.86 Million |
0.538x | -1.95% |
| 2010-12-31 | €-7.21 Million ≈ $-8.43 Million |
€-3.95 Million ≈ $-4.62 Million |
0.548x | +146.47% |
| 2009-12-31 | €4.79 Million ≈ $5.59 Million |
€-5.65 Million ≈ $-6.60 Million |
-1.180x | -26.13% |
| 2008-12-31 | €12.02 Million ≈ $14.06 Million |
€-11.25 Million ≈ $-13.15 Million |
-0.935x | -644.25% |
| 2007-12-31 | €70.29 Million ≈ $82.17 Million |
€12.08 Million ≈ $14.12 Million |
0.172x | +319.22% |
| 2006-12-31 | €128.12 Million ≈ $149.78 Million |
€-10.04 Million ≈ $-11.74 Million |
-0.078x | +32.33% |
| 2005-12-31 | €133.96 Million ≈ $156.61 Million |
€-15.52 Million ≈ $-18.15 Million |
-0.116x | -122.40% |
| 2004-12-31 | €29.63 Million ≈ $34.64 Million |
€15.33 Million ≈ $17.92 Million |
0.517x | +15.67% |
| 2003-12-31 | €55.51 Million ≈ $64.89 Million |
€24.82 Million ≈ $29.02 Million |
0.447x | -- |
About TELES Informationstechnologien AG
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.